Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques

Authors

  • Jordi Bruix,

    Corresponding author
    1. Barcelona Clinic Liver Cancer group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
    • Barcelona Clinic Liver Cancer group, Liver Unit, CIBEREHD, IDIBAPS, Hospital Clínic, c/Villarroel, 170, Escala 11, 4a planta, 08036 Barcelona, Spain
    Search for more papers by this author
    • fax: +34 932275792

  • Maria Reig,

    1. Barcelona Clinic Liver Cancer group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
    Search for more papers by this author
  • Jordi Rimola,

    1. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
    2. Barcelona Clinic Liver Cancer (BCLC) group, Radiology Department, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    Search for more papers by this author
  • Alejandro Forner,

    1. Barcelona Clinic Liver Cancer group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
    Search for more papers by this author
  • Marta Burrel,

    1. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
    2. Barcelona Clinic Liver Cancer (BCLC) group, Radiology Department, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    Search for more papers by this author
  • Ramón Vilana,

    1. Barcelona Clinic Liver Cancer group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    Search for more papers by this author
  • Carmen Ayuso

    1. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
    2. Barcelona Clinic Liver Cancer (BCLC) group, Radiology Department, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain
    Search for more papers by this author

  • Potential conflict of interest: Dr. Bruix is a consultant for, advises, is on the speakers' bureau of, and received grants from Bayer. He is a consultant for and advises Bristol-Myers Squibb. He is also a consultant for Biocompatibles, GlaxoSmithKline, Kowa, Novartis, and ArQule.

  • This work was supported a grant from Instituto de Salud Carlos III (PI08/0146). CIBERehd is funded by Instituto de Salud Carlos III. M.R. was supported by a grant from the University of Barcelona (APIF RD63/2006).

Ancillary